Voxzogo 0.56mg-EU (Vosoritide Vials) 0.56mg

Voxzogo 0.56mg-EU (vosoritide) is a prescription medication used to treat achondroplasia in pediatric patients. This injectable vial form supports growth regulation in children with this condition. Store between 2-8°C to maintain potency. Always follow healthcare provider guidance when using.

Strength

0.56mg

Pack Size

10s

Storage

2-8°

Manufacturer / TM Owner

BioMarin International Limited

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Voxzogo 0.56mg-EU is used to manage achondroplasia, a genetic condition affecting bone growth in children. It works by regulating growth pathways to support skeletal development. Parents and caregivers often ask what is vosoritide used for, and this medication is specifically indicated for pediatric patients with confirmed achondroplasia. It is not a cure but may help improve growth outcomes when administered as directed.

Side Effects

Voxzogo 0.56mg-EU is designed to influence growth processes in children with achondroplasia. Users may notice changes in growth patterns over time with consistent use. The effects are typically monitored by a healthcare professional to assess progress. Some patients experience mild injection-site reactions, which are common with subcutaneous treatments.

Precautions & Warnings

Voxzogo 0.56mg-EU should be handled with care to maintain sterility and potency. Store vials refrigerated between 2-8°C and protect from light. Avoid freezing or shaking the vials. Always check the expiration date before use and discard if the solution appears discolored or contains particles. Keep out of reach of children and pets.

Avoid Interactions

Limited information is available on drug interactions with vosoritide. However, caution is advised when combining with other medications that may affect bone metabolism. Always inform your healthcare provider about all medications, supplements, or herbal products being used. No specific interactions have been widely reported, but professional guidance is recommended.

Frequently Asked Questions

Voxzogo 0.56mg-EU is used to treat achondroplasia in pediatric patients by supporting growth regulation.

Store vials refrigerated between 2-8°C and protect from light. Do not freeze or shake.

Voxzogo 0.56mg-EU is not a cure but may help improve growth outcomes in pediatric patients with achondroplasia.

Voxzogo 0.56mg-EU is specifically indicated for pediatric patients with achondroplasia.

Mild injection-site reactions are common. Always consult a healthcare provider for personalized advice.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.